ALB and hepatocellular carcinoma: Several existing prognostic models, including the four-and-seven criteria, six-and-12 score, hepatoma arterial-embolization prognostic (HAP) scores, and albumin-bilirubin grade, have been proposed to predict clinical outcome after TACE (4–7).